Skip to main content Skip to main navigation menu Skip to site footer
Global Cardiology

eISSN 2975-2728

  • About the Journal
  • Editorial Board
  • Publication Ethics
  • Current
  • Archives
  • Special Issues
    • Overview
  • Copyright & Licensing
  • Register
  • Login
  • Search
  • Contacts
  • News

Editor-in-Chief: Andrew J.S. Coats, Australia

Submit
an article
  1. Home /
  2. Search

Search

Advanced filters
Published After
Published Before

Search Results

##search.searchResults.foundPlural##
  • Adherence to lifestyle therapy in patients with chronic heart failure and comorbidity

    Elena Efremova, Alexander Shutov
    2023-12-20
    https://doi.org/10.4081/cardio.2023.8
    1432
    pdf: 385
    HTML: 46
  • Clinical trial design, endpoints and regulatory considerations in heart failure

    Giuseppe M.C. Rosano
    2024-03-28
    https://doi.org/10.4081/cardio.2024.18
    5964
    PDF: 559
    HTML: 69
  • Mavacamten’s therapeutic impact: cardiac-specific myosin inhibition in obstructive hypertrophic cardiomyopathy

    Ahmad Shabbir, Laiba Yumn, Esha Khan
    2024-11-05
    https://doi.org/10.4081/cardio.2024.48
    2459
    PDF: 670
    HTML: 0
  • The association of iron deficiency with right ventricular dysfunction in Africans with heart failure

    Adeseye A. Akintunde, Sope T. Orugun
    2024-12-30
    https://doi.org/10.4081/cardio.2024.53
    2673
    PDF: 447
    Appendix B: 500
    Appendix A: 348
    HTML: 10
  • Prevalence of left ventricular dysfunction and relationship with serum selenium in apparently healthy pregnant women: results from the PEACE registry

    Kamilu M. Karaye, Idris Y. Mohammed, Hadiza Sa’idu, Naser A. Ishaq, Suleiman A. Balarabe, Jamilu Tukur, Tewogbade A. Adedeji, Olufemiwa N. Makinde, Rasaaq A. Adebayo
    2024-06-28
    https://doi.org/10.4081/cardio.2024.36
    1725
    PDF: 473
    HTML: 23
  • Bridging the gap: integrating stress echocardiography, iFR, CFR, and FFR in the evaluation of coronary artery disease

    Konstantinos Stamos, Theodora Delaporta, Antonios Delaportas
    2025-04-16
    https://doi.org/10.4081/cardio.2025.66
    1622
    PDF: 589
    HTML: 0
  • To clip or not to clip moderate-to-severe functional mitral regurgitation in patients with heart failure?

    Muhammad Shahzeb Khan, Javed Butler, Tim Friede, Piotr Ponikowski, Stefan D. Anker
    2024-11-05
    https://doi.org/10.4081/cardio.2024.44
    3137
    PDF: 866
    HTML: 39
  • Prognostic factors and outcome in patients submitted into coronary artery bypass surgery with total arterial myocardial revascularization

    Elias Tassoulas, Dimitrios Tasoulas, Christos Papaconstantinou, Ioannis Chlorogiannis
    2024-12-30
    https://doi.org/10.4081/cardio.2024.46
    3041
    PDF: 534
    HTML: 37
  • Anomalous origin of right coronary artery from the pulmonary artery: an incidental finding on cardiac computed tomography in a patient presenting with dyspnea

    Rachel Anne Xuereb, Sara Xuereb, Kentaro Yamagata, Robert George Xuereb
    2024-03-28
    https://doi.org/10.4081/cardio.2024.24
    1633
    PDF: 286
    HTML: 21
  • Clinical profiles and short-term outcomes of women with peripartum and dilated cardiomyopathies

    Babalawan Muhammad, Naser A. Ishaq, Kamilu M. Karaye
    2024-11-05
    https://doi.org/10.4081/cardio.2024.42
    2300
    PDF: 662
    HTML: 9
  • Rationale and design for the peripartum cardiomyopathy in Nigeria (PEACE) registry

    Kamilu M. Karaye, Idris Y. Mohammed, Okechukwu S. Ogah, Basil N. Okeahialam
    2023-11-28
    https://doi.org/10.4081/cardio.2023.4
    1185
    pdf: 320
    HTML: 67
  • SGLT2 inhibitors and risk reduction for mortality in high-risk patients: a meta-analysis of randomized controlled trials

    Tariq Jamal Siddiqi, Javed Butler, Andrew J.S. Coats, Subodh Verma, Tim Friede, Gerasimos Filippatos, Stefan D. Anker
    2023-11-23
    https://doi.org/10.4081/cardio.2023.2
    1463
    pdf: 343
    Supplementary Material: 67
    HTML: 203
  • Evolving targets for heart failure: the journey so far

    Giuseppe M.C. Rosano, Jerneja Farkas
    2023-11-28
    https://doi.org/10.4081/cardio.2023.6
    2372
    pdf: 440
    HTML: 4
  • Elevated left ventricular end diastolic pressure, chronic pulmonary oedema and valve disease

    Prithwish Banerjee
    2024-04-08
    https://doi.org/10.4081/cardio.2024.23
    2329
    PDF: 301
    HTML: 1039
  • Large language models to write scientific manuscripts: to be considered but not trusted

    Christian Basile, Stefan D. Anker, Gianluigi Savarese
    2025-06-30
    https://doi.org/10.4081/cardio.2025.74
    930
    PDF: 340
    HTML: 14
  • Importance of patient-reported outcomes in cardiovascular illnesses

    Wardah Rasool, Ahmed Kamal Siddiqi, Laibah Arshad Khan
    2025-06-30
    https://doi.org/10.4081/cardio.2025.69
    2408
    PDF: 562
    HTML: 176
  • Unveiling the genetic aetiology of non-genetic dilated cardiomyopathy

    Emanuele Monda, Giuseppe Limongelli
    2024-12-30
    https://doi.org/10.4081/cardio.2024.54
    2832
    PDF: 528
    HTML: 15
  • Elevated endostatin is associated with hypertension treatment, elevated high sensitivity C-reactive protein, increased waist-hip ratio, and attenuated kidney function, but not with age, in a middle-aged population

    Anders Larsson, Bertil Wegmann, Toralph Ruge, Joakim Alfredsson, Carl Johan Östgren, Tomas Lindahl
    2025-04-16
    https://doi.org/10.4081/cardio.2025.64
    2866
    PDF: 576
    HTML: 12
  • Frequency of low-density-lipoprotein-cholesterol measurement and risk of major adverse cardiovascular outcomes: a 5-million-person nationwide cohort study

    Denis M. Ngina, Wolfram Doehner, George Ntaios, Yvonne Nartey, Ralph K. Akyea
    2025-09-30
    https://doi.org/10.4081/cardio.2025.85
    579
    PDF: 94
    HTML: 67
  • The effect of SGLT2 inhibitors on health status in patients with heart failure: a systematic review and meta-analysis

    Muhammad Shariq Usman, Arsalan Hamid, Shurjeel Uddin Qazi, Mikhail N. Kosiborod, Deepak L. Bhatt, Muhammad Shahzeb Khan, Muthiah Vaduganathan, Javed Butler
    2024-06-28
    https://doi.org/10.4081/cardio.2024.35
    3430
    PDF: 797
    Conflict of interest: 355
    SUPPLEMENTARY MATERIAL: 299
    HTML: 90
  • Preferential vasodilator effects of levosimendan in resistance pulmonary arteries in a rodent pulmonary embolism model

    Camila Bedo, Juan C. Grignola
    2024-03-28
    https://doi.org/10.4081/cardio.2024.25
    1599
    PDF: 295
    HTML: 18
  • Safety and efficacy of left atrial appendage closure in cancer versus non-cancer patients: a systematic review and meta-analysis

    Muhammad Ahmed, Fatima Muskan, Mohsin Zaheer, Manesh Kumar, Sawera Gul, Abdul Hadi Ansari, Muhammad Sameer Jamal, Muhammad Sohaib Asghar, M. Chadi Alraies, Shiny Teja Kolli, Praveen Kumar Komminni, Priya Hotwani, Vishal Reddy Bejugam
    2025-06-30
    https://doi.org/10.4081/cardio.2025.72
    1427
    PDF: 391
    Supplementary: 198
    HTML: 160
  • The impact of diurnal fasting during Ramadan on patients with established cardiac disease: a systematic review

    Marwan M. Refaat, Nadim El Jamal, Hebah M. El-Rayess, Anthony Gebran, Amar M. Salam
    2024-06-28
    https://doi.org/10.4081/cardio.2024.32
    3360
    PDF: 1242
    HTML: 28
  • COVID-19 myocarditis

    Reinaldo B. Bestetti, Rosemary Furlan-Daniel, Luciano P. Pereira
    2024-03-28
    https://doi.org/10.4081/cardio.2024.21
    3137
    PDF: 370
    HTML: 14
  • Aspirin underuse in secondary prevention: beyond access and adherence

    Fasih Mehmood, Nayab Magsi, Arslan Tariq
    2026-06-19
    https://doi.org/10.4081/cardio.2026.105
    31
    PDF: 22
    HTML: 0
  • Modulation of cardiac metabolism in heart failure

    Giuseppe M.C. Rosano, Andrew J.S. Coats
    2024-11-05
    https://doi.org/10.4081/cardio.2024.30
    2583
    PDF: 1260
    HTML: 80
  • Biological plausibility and implications of obesity associated valvular heart diseases

    Francesco Fioretti, Brian R. Lindman, Javed Butler
    2024-11-05
    https://doi.org/10.4081/cardio.2024.49
    2899
    PDF: 868
    HTML: 34
  • Bridging the gap between study outcomes and real-world results. Algorithm-driven management in a rural cardioMEMS population

    Marc Atzenhoefer, Elizabeth Dille, Rebecca Steinke, Nicole Weigert, Keri Sabel, Kirsten Rasmussen
    2025-04-16
    https://doi.org/10.4081/cardio.2025.63
    3821
    PDF: 827
    HTML: 61
  • Preliminary study on the immunohistochemical expression of galectin-3 in hypertrophic hearts

    Cecilia Salzillo, Lorenzo Giovannico, Giuseppe Fischetti, Gerardo Cazzato, Mario Magistro, Grazia Nucci, Gabriella Serio, Andrea Marzullo
    2024-06-28
    https://doi.org/10.4081/cardio.2024.37
    1544
    PDF: 409
    HTML: 28
  • How organ care system saved the day during a donation after circulatory death heart transplant: a case of complicated sternal re-entry

    Shiva Seyed Mokhtassi, Nika Majidi, Yousuf Salmasi, Akhil Sonecha, Sanjay Agrawal, Mubassher Husain, Diana Garcia, Jerry Mitchell, Espeed Khoshbin
    2025-04-16
    https://doi.org/10.4081/cardio.2025.60
    3313
    PDF: 633
    HTML: 34
  • Relaxin-2 for heart failure with preserved ejection fraction: a comment on the termination of a phase-II trial investigating the relaxin-2 analogue, LY3540378

    Thomas Bernd Dschietzig, Guy Salama
    2024-12-30
    https://doi.org/10.4081/cardio.2024.56
    4722
    PDF: 997
    HTML: 119
  • Intervention options: depression and cardiovascular disease during COVID-19

    Eirini Flouda, Athena Stefanatou, Tinia Apergi
    2023-11-28
    https://doi.org/10.4081/cardio.2023.5
    2013
    pdf: 364
    HTML: 35
  • Encasement of the left anterior descending coronary artery: association with Takotsubo syndrome, and diagnostic and therapeutic options

    Stefan Peters
    2023-12-21
    https://doi.org/10.4081/cardio.2023.16
    880
    pdf: 261
    HTML: 25
  • Tricuspid valve fungal endocarditis in a patient with breast cancer and an implantable chemotherapy venous access port

    Petros Fountoulakis, Aikaterini Siama, Aimilianos Kalogeris, Marianthi Iliopoulou, Athanasios Tsoukas, Athanasios Manolis
    2023-12-18
    https://doi.org/10.4081/cardio.2023.7
    864
    pdf: 227
    HTML: 25
51 - 84 of 84 items << < 1 2 

authors

FOR AUTHORS
  • SUBMIT YOUR PAPER
  • Guide for Authors
  • Benefits for Authors
  • How to write a Scientific paper
  • How to write a Review article
  • Article Processing Charge

indexing

INDEXING
  • DOAJ
  • Google Scholar
  • OpenAlex
  • Scilit
  • Analytics

iCARDIO

May 1 marked the release of the #iCARDIO Guidelines on Heart Failure, now live in Global Cardiology. This global-first effort brings flexible, practical guidance to frontline providers managing #heartfailure in any setting. www.globalcardiology.info/site/article... #GlobalHealth #cardiosky

[image or embed]

— iCardio (@icardio.bsky.social) May 13, 2025 at 8:26

Keywords

Vol. 4 No. 1 (2026)
Draft Document for Public Consultation: iCARDIO Alliance Global Implementation Guidelines on Ischemic Heart Disease Management 2026

Ischemic heart disease (IHD) remains the leading cause of morbidity and mortality worldwide.  Coronary artery disease (CAD) encompasses any pathological process capable of compromising myocardial perfusion and although numerous etiologies exist, including vasculitis, spontaneous coronary artery dissection, and coronary embolism, the majority of CAD is attributable to coronary atherosclerosis, which constitutes the focus of this document. For practical purposes, CAD is considered present when any degree of atherosclerotic involvement...

Writing Task Force | iCARDIO-Alliance
5 February 2026
Vol. 4 No. 2 (2026)
Filling the void: digoxin and the first randomized evidence in rheumatic heart disease

The Digoxin in Rheumatic Heart Disease (Dig-RHD) trial marks an important shift in rheumatic heart disease by replacing long-standing therapeutic assumption with direct randomized evidence. In a condition affecting predominantly young patients in low- and middle- income countries, practice has often relied on extrapolation from non-valvular heart failure populations despite clear differences in disease biology, treatment access, and clinical context. By reducing heart failure events in symptomatic patients, Dig-RHD suggests that the value...

Viana Copeland et al.
3 July 2026
Vol. 4 No. 2 (2026)
Familial hypercholesterolemia: state-of-the-art

Familial hypercholesterolemia (FH) affects about 20 million people worldwide and remains markedly underdiagnosed and undertreated. Contemporary studies estimate the prevalence of heterozygous FH (HeFH) at 1 in 192 to 1 in 310, and the prevalence of homozygous FH (HoFH) at about 1 in 300,000. The 2016 United States National Health and Nutrition Examination Survey estimated FH prevalence at 1 in 250 adults. Untreated HeFH causes fatal coronary events before age 55 in about 50% of men and before age 60 in about 15% of women. Pathogenic...

Ahmed Kamal Siddiqi et al.
29 June 2026
Global Cardiology

is an Open Access, peer-reviewed journal published online by PAGEPress®, Pavia, Italy.
[Website continuously updated]

eISSN: 2975-2728

Info

  • About
  • Editorial Board
  • News

Info Submission

  • Submission
  • Guidelines For Authors
Themes by Openjournaltheme.com

© PAGEPress 2008-2026    •    PAGEPress® is a registered trademark property of PAGEPress srl, Italy    •    VAT: IT02125780185    •    Privacy